Dr. Antonia Brancia Maxon, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 354 Hartford Tpke, Hampton, CT 06247 Phone: 860-455-1404 Fax: 860-455-1396 |
New England Center For Hearing Rehabilitation Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 354 Hartford Tpke, Hampton, CT 06247 Phone: 860-455-1404 Fax: 860-455-1396 |
Dr. Hannah Liadan Weaver, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 354 Hartford Tpke, Hampton, CT 06247 Phone: 860-287-7735 |
Ms. Jennifer Cox, AU.D., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 354 Hartford Tpke, Hampton, CT 06247 Phone: 860-455-1404 Fax: 860-455-1396 |
Mrs. Kristin Amanda Dilaj, AUD, CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 354 Hartford Tpke, Hampton, CT 06247 Phone: 860-455-1404 |
New England Center For Hearing Rehabilitation Llc Audiologist Medicare: Medicare Enrolled Practice Location: 354 Hartford Tpke, Hampton, CT 06247 Phone: 860-455-1404 Fax: 860-455-1396 |
News Archive
Myriad Pharmaceuticals, Inc today announced that it has received a notice from Javelin Pharmaceuticals, Inc. of its intent to terminate the merger agreement between the two companies.
A new Centers for Disease Control and Prevention study found that smoking in the three months prior to assisted reproductive technology treatment was associated with higher adjusted odds of cycle cancellation resulting in no embryo transfer and cancellations before fresh oocyte retrieval or frozen embryo transfer.
GeneGo, Inc., the leading systems biology company, today announced that it has been awarded a grant from the National Institute on Drug Abuse to develop an integrated systems biology platform for research into the causes and treatment of tobacco dependence, nicotine addiction, smoking cessation and tobacco/nicotine withdrawal.
Over four times as many patients with a rapidly fatal type of brain cancer, glioblastoma multiforme (GBM), who are treated with the chemotherapy drug temozolomide (TMZ) and radiation therapy, can live for four years after diagnosis, compared to those who receive only radiation treatment, according to updated results of a large, international trial presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
GE Healthcare, a unit of General Electric Company today will commence a cash tender offer to purchase all outstanding shares of common and preferred stock of Clarient, Inc. through a wholly owned subsidiary of GE, Crane Merger Sub, Inc.
› Verified 9 days ago